Want to see CVS full AI Analyst Report?
CVS Stock Chart & Stats
$77.30
-$0.04(-0.09%)
At close: 4:00 PM EST
$77.30
-$0.04(-0.09%)
Day’s Range― - ―
52-Week Range$58.50 - $106.15
Previous CloseN/A
Volume5.40M
Average Volume (3M)8.99M
Market Cap
$133.73B
Enterprise Value$195.32B
Total Cash (Recent Filing)$11.80B
Total Debt (Recent Filing)$78.34B
Price to Earnings (P/E)45.4
Beta0.51
Next Earnings
Aug 05, 2026EPS Estimate
1.83Next Dividend Ex-DateN/A
Dividend Yield3.41%
Share Statistics
EPS (TTM)2.31
Shares Outstanding1,275,927,200
10 Day Avg. Volume9,609,227
30 Day Avg. Volume8,994,894
Financial Highlights & Ratios
PEG Ratio-0.92
Price to Book (P/B)1.34
Price to Sales (P/S)0.25
P/FCF Ratio12.88
Enterprise Value/Market Cap1.46
Enterprise Value/Revenue0.48
Enterprise Value/Gross Profit3.45
Enterprise Value/Ebitda17.55
Forecast
1Y Price Target
$106.00Price Target Upside37.13% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering16
EPS Forecast (FY)7.41
Revenue Forecast (FY)$408.50B
Bulls Say, Bears Say
Bulls Say
Vertical Integration And ScaleCVS's integrated model linking Aetna, Caremark and retail pharmacy creates durable competitive advantages: it can retain members, steer prescriptions to owned channels, and coordinate care to lower total medical costs. This structural linkage supports long‑term revenue capture and cross‑segment synergies that persist beyond near‑term cycles.
Consistent Cash Generation And Free Cash FlowSustained operating cash generation and positive free cash flow provide durable financial flexibility: funds can support deleveraging, targeted reinvestment (health delivery, tech/AI), dividends and strategic initiatives. Even with cyclical earnings, steady cash conversion underpins long‑term capital allocation choices and resilience to shocks.
Aetna Margin Recovery And Operational GainsMaterial improvement at Aetna indicates a sustainable path to better insurance unit economics: lower medical benefit ratios and demonstrated AOI gains reduce headline volatility in Health Care Benefits. Aetna's operational improvements can drive multi-year profit recovery and improve enterprise earnings power if maintained through cost management and care initiatives.
Bears Say
Profitability Compression And Weak ReturnsMargins and returns have materially deteriorated, reducing the balance sheet’s earnings power. Persistent compression limits reinvestment, slows deleveraging opportunities, and makes it harder to generate sustained ROE and cash‑flow growth. Absent durable margin recovery, scale alone won't translate into commensurate shareholder returns.
PBM Rebate Guarantees And Margin HeadwindsStructural shifts in PBM economics—rebate guarantees, client price concessions and purchasing timing—erode spread margins that historically drove HSS profitability. These dynamics are multi‑period, reduce predictable earnings, and force either scale re‑engineering or margin tradeoffs with clients, pressuring long‑run PBM operating income.
Regulatory And State‑level UncertaintyFragmented state rules and evolving federal guidance create persistent operational and legal risk for both retail pharmacy and PBM businesses. Regulatory changes can alter reimbursement, network design and pricing mechanics, raising long‑term compliance costs and forcing strategy shifts that could materially affect revenue mix and margin sustainability.
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was $58.50 and its highest was $106.15 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is $133.73B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Aug 05, 2026 which is in 34 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on May 06, 2026. The company reported $2.57 earnings per share for the quarter, beating the consensus estimate of $2.184 by $0.386.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of $0.665 which represents an annual dividend yield of 3.41%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 1.83.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,275,927,200 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of $2.57 in its last earnings report, beating expectations of $2.184. Following the earnings report the stock price went up 7.647%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in CVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVS Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$106.00 (37.13% Upside)
$106.00 (37.13% Upside)
Blogger Sentiment
Bullish
CVS Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 18.9M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $323.7M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 0.7%
Last 30 Days ▼ 0.1%
Last 30 Days ▼ 0.1%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
55.45%
12-Months-Change
Fundamentals
Return on Equity
3.87%
Trailing 12-Months
Asset Growth
-1.02%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
CVS Company Deck
CVS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a generally positive tone driven by clear top-line growth, strong cash generation, profit and EPS beats, an upward revision to full-year EPS guidance, meaningful improvement at Aetna (material AOI gain and operational efficiencies), and ongoing technology/AI initiatives (Health100). Offsetting risks include segment-level profit declines (Health Services and PCW), membership impacts from the Individual Exchange exit, continued elevated medical cost trends, PBM rebate pressures and regulatory/state-level uncertainty. On balance, the favorable operating metrics, raised guidance, and credible path to margin recovery outweighed the identifiable challenges.View all CVS earnings summariesCVS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other

CVS Stock 12 Month Forecast
All Analysts
Top Analysts
Average Price Target
$106.00
▲(37.13% Upside)
Technical Analysis
1 Day
3 Days
1 Week
1 Month
Ownership Overview
0.41% Insiders
32.79% Mutual Funds
0.03% Other Institutional Investors
44.09% Public Companies and Individual Investors













